Life Science

Tedor Pharma Announces Renovation of Manufacturing Facility

Managed by Shawmut

Cumberland, RI – Tedor Pharma Inc., a Cumberland-based U.S. pharmaceutical product developer and manufacturer, is expanding and upgrading its large-scale manufacturing facility located at 400 Highland Corporate Drive. The multimillion dollar project is being managed by Shawmut Design and Construction. The expansion, which will add approximately 5,400sf to the existing 40,000sf facility, has already broken ground and is expected to be completed by May of 2017.

Shawmut will oversee the project, that will include the renovation of 3,300sf of existing space as well as a 2,100sf addition. Modifications within the existing facility footprint will upgrade the space to include several cGMP production suites.

The suites will include new equipment to expand capacity and capability, primarily a large-scale 60-cubic-foot V-blender and a state-of-the-art fluid bed processor. Additionally, the suites will include the flexibility to utilize mobile equipment such as high-speed tablet presses and encapsulators for solid oral dose manufacturing.

The external addition will be utilized to house several key utility systems to feed the fluid bed processor, including a clean-steam boiler, air compressor, and air handling system. The building also has been oversized to accommodate future expansion plans.


The project will double Tedor’s commercial capacity and capabilities in order to execute on its rapidly-growing product portfolio. As a result of Tedor’s growth, it plans to expand its current high-skilled workforce of 60 employees by adding more than 20 new positions in 2017.

“This investment is in response to our clients’ demand for larger scale, multi-purpose manufacturing capabilities,” said Carl Wooten, CEO/President, Tedor Pharma. “The manufacturing addition and investment in several technologies will double our capacity and will allow us to add sought after high-skilled jobs to the local economy.”

“We are excited to team up with Tedor Pharma on this expansion and to contribute to their growth and addition of high-skilled jobs in Rhode Island,” said Les Hiscoe, CEO of Shawmut Design and Construction.

The expansion is phase one of Tedor’s three near-term capital improvements, which are an ongoing strategic effort to expand production capabilities and invest in facilities for new formulations to broaden its customer portfolio